SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 128 filers reported holding SAGENT PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $282,223,000 | +36.3% | 18,840 | +10.8% | 0.00% | 0.0% |
| Q1 2016 | $207,000,000 | -19.5% | 17,004 | +5.1% | 0.00% | 0.0% |
| Q4 2015 | $257,000,000 | +104798.0% | 16,178 | +1.2% | 0.00% | 0.0% |
| Q3 2015 | $245,000 | -99.9% | 15,981 | +1.5% | 0.00% | -50.0% |
| Q2 2015 | $382,858,000 | -0.3% | 15,749 | -4.6% | 0.00% | 0.0% |
| Q1 2015 | $383,881,000 | -6.8% | 16,511 | +0.7% | 0.00% | 0.0% |
| Q4 2014 | $411,754,000 | -21.6% | 16,398 | -2.9% | 0.00% | 0.0% |
| Q3 2014 | $525,186,000 | +41.9% | 16,887 | +18.0% | 0.00% | 0.0% |
| Q2 2014 | $370,134,000 | +23.8% | 14,313 | +11.9% | 0.00% | +100.0% |
| Q1 2014 | $299,019,000 | -5.7% | 12,795 | +2.5% | 0.00% | -50.0% |
| Q4 2013 | $316,945,000 | +38.9% | 12,488 | +11.6% | 0.00% | +100.0% |
| Q3 2013 | $228,174,000 | +68.3% | 11,185 | +73.1% | 0.00% | 0.0% |
| Q2 2013 | $135,552,000 | – | 6,461 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Timpani Capital Management LLC | 110,215 | $2,248,000 | 1.32% |
| Healthcare Value Capital, LLC | 73,822 | $1,506,000 | 1.32% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,014,863 | $20,703,000 | 0.96% |
| Perimeter Capital Partners, LLC | 248,893 | $5,077,000 | 0.94% |
| Tekla Capital Management LLC | 270,031 | $5,509,000 | 0.61% |
| SECTORAL ASSET MANAGEMENT INC | 564,325 | $11,512,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 168,268 | $3,432,000 | 0.35% |
| MENTA CAPITAL LLC | 30,480 | $622,000 | 0.32% |
| KOPP INVESTMENT ADVISORS LLC | 39,934 | $815,000 | 0.30% |
| Broadfin Capital, LLC | 68,300 | $1,393,000 | 0.25% |